These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 9369950

  • 1. Heparin suppresses sgk, an early response gene in proliferating vascular smooth muscle cells.
    Delmolino LM, Castellot JJ.
    J Cell Physiol; 1997 Dec; 173(3):371-9. PubMed ID: 9369950
    [Abstract] [Full Text] [Related]

  • 2. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm.
    Tapon-Bretaudière J, Drouet B, Matou S, Mourão PA, Bros A, Letourneur D, Fischer AM.
    Thromb Haemost; 2000 Aug; 84(2):332-7. PubMed ID: 10959709
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
    Pukac LA, Carter JE, Ottlinger ME, Karnovsky MJ.
    J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
    [Abstract] [Full Text] [Related]

  • 4. Heparin rapidly and selectively regulates protein tyrosine phosphorylation in vascular smooth muscle cells.
    Mishra-Gorur K, Castellot JJ.
    J Cell Physiol; 1999 Feb; 178(2):205-15. PubMed ID: 10048585
    [Abstract] [Full Text] [Related]

  • 5. COP-1, a member of the CCN family, is a heparin-induced growth arrest specific gene in vascular smooth muscle cells.
    Delmolino LM, Stearns NA, Castellot JJ.
    J Cell Physiol; 2001 Jul; 188(1):45-55. PubMed ID: 11382921
    [Abstract] [Full Text] [Related]

  • 6. Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin.
    Reilly CF.
    J Cell Physiol; 1990 Feb; 142(2):342-51. PubMed ID: 2154504
    [Abstract] [Full Text] [Related]

  • 7. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization.
    Logeart D, Prigent-Richard S, Jozefonvicz J, Letourneur D.
    Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor-beta regulates increased ductus arteriosus endothelial glycosaminoglycan synthesis and a post-transcriptional mechanism controls increased smooth muscle fibronectin, features associated with intimal proliferation.
    Boudreau N, Clausell N, Boyle J, Rabinovitch M.
    Lab Invest; 1992 Sep; 67(3):350-9. PubMed ID: 1405493
    [Abstract] [Full Text] [Related]

  • 9. Isolation of vascular smooth muscle cell cultures with altered responsiveness to the antiproliferative effect of heparin.
    Caleb BL, Hardenbrook M, Cherington V, Castellot JJ.
    J Cell Physiol; 1996 May; 167(2):185-95. PubMed ID: 8613458
    [Abstract] [Full Text] [Related]

  • 10. Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta 1 and heparin.
    Orlandi A, Ropraz P, Gabbiani G.
    Exp Cell Res; 1994 Oct; 214(2):528-36. PubMed ID: 7925646
    [Abstract] [Full Text] [Related]

  • 11. The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells.
    Xue L, Shireman PK, Hampton B, Burgess WH, Greisler HP.
    J Surg Res; 2000 Aug; 92(2):255-60. PubMed ID: 10896831
    [Abstract] [Full Text] [Related]

  • 12. Ca(2+)/calmodulin-dependent protein kinase II inhibition by heparin in mesangial cells.
    Xiao W, Liu Y, Templeton DM.
    Am J Physiol Renal Physiol; 2005 Jan; 288(1):F142-9. PubMed ID: 15383398
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor-beta 1 proliferated vascular smooth muscle cells from spontaneously hypertensive rats.
    Sato M, Ohsaki Y, Tobise K.
    Am J Hypertens; 1995 Feb; 8(2):160-6. PubMed ID: 7755944
    [Abstract] [Full Text] [Related]

  • 14. The serum- and glucocorticoid-inducible kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin.
    BelAiba RS, Djordjevic T, Bonello S, Artunc F, Lang F, Hess J, Görlach A.
    Circ Res; 2006 Mar 31; 98(6):828-36. PubMed ID: 16484615
    [Abstract] [Full Text] [Related]

  • 15. Endothelial heparan sulfate is necessary but not sufficient for control of vascular smooth muscle cell growth.
    Ettenson DS, Koo EW, Januzzi JL, Edelman ER.
    J Cell Physiol; 2000 Jul 31; 184(1):93-100. PubMed ID: 10825238
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of serum and transforming growth factor beta (TGF-beta1)-induced DNA synthesis in confluent airway smooth muscle by heparin.
    Okona-Mensah KB, Shittu E, Page C, Costello J, Kilfeather SA.
    Br J Pharmacol; 1998 Oct 31; 125(4):599-606. PubMed ID: 9831891
    [Abstract] [Full Text] [Related]

  • 17. Characterization of [3H]-heparin binding in human vascular smooth muscle cells and its relationship to the inhibition of DNA synthesis.
    Patel MK, Refson JS, Schachter M, Hughes AD.
    Br J Pharmacol; 1999 May 31; 127(2):361-8. PubMed ID: 10385234
    [Abstract] [Full Text] [Related]

  • 18. Human endothelial cells are stimulated and vascular smooth muscle cells are inhibited in their proliferation and migration by heparins.
    Hämmerle H, Betz E, Herr D.
    Vasa; 1991 May 31; 20(3):207-15. PubMed ID: 1659056
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of IFN-beta1b on the proliferation of human vascular smooth muscle and endothelial cells.
    Mintzer RJ, Croze E, Rubanyi GM, Johns A.
    J Interferon Cytokine Res; 1998 Nov 31; 18(11):939-45. PubMed ID: 9858315
    [Abstract] [Full Text] [Related]

  • 20. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serum.
    Grainger DJ, Witchell CM, Watson JV, Metcalfe JC, Weissberg PL.
    Cardiovasc Res; 1993 Dec 31; 27(12):2238-47. PubMed ID: 8313434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.